Clinical Trials | February 11, 2026
Veradermics completes enrollment in both Phase 3 male hair loss trials
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
The FDA’s regulatory decision is expected in Q2 2026 under the Prescription Drug User Fee Act (PDUFA)
With its unique combination of AI, population-specific research, and international collaboration, BioMed X’s Barbados project represents a bold new frontier in precision medicine for diabetes and kidney disease
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices
The platform uses cutting-edge AI and automation to tackle the entire revenue cycle
Subscribe To Our Newsletter & Stay Updated
